Many Compound Drugs No Longer Covered by Wellmark

Effective October 1, 2012, Wellmark has made a change to the Wellmark Drug List that will affect member coverage of compound drugs. 

The Wellmark Drug List is a list of drugs that have been approved for members by a group of community physicians and pharmacists. Wellmark continually reviews the Wellmark Drug List and makes changes based on new findings from the Food and Drug Administration (FDA) and drug makers and other factors including cost. 

Several products used for compounded drug preparations were determined to not be FDA approved. Wellmark is removed these products from the Wellmark Drug List effective October 1, 2012. Compound prescriptions incorporating these products will no longer be covered by Blue RxSM or Blue Rx PreferredSM benefit plans. Members who receive a compounded prescription with these products should expect to pay the full retail cost after October 1. 

Members who had filled compound prescriptions with one of the affected products were alerted to the formulary change in early September. For questions about how this will affect you, please contact Wellmark at (800) 355-2031.